This issue of the ACRIA Update gives an introduction to the science underlying HIV drug development, with a description of the stages of the HIV life cycle at which drugs are currently being targeted. 

It also includes useful articles (written by US- and South Africa-based authors) on the actions and side effects of existing brand-named drugs, dosing regimens, an outline of the drug development process, and an individual's experience of surviving more than a decade on HIV treatment.


Related topics